Horama Company
Horama develops gene therapies for rare inherited ocular diseases.
Technology:
Neurological Disorders
Industry:
Gene Therapy
Headquarters:
Paris, Ile-de-France, France
Founded Date:
2014
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
9
Total Funding:
â¬27.1M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series B
Register and Claim Ownership